Effect of Bariatric Surgery on Cognition, Genetics and Lifestyle
1 other identifier
observational
100
1 country
1
Brief Summary
Obesity bariatric surgery patients usually lose more than 50% of their former obesity within a relatively short time (\~ 2 years). There is still a lack of knowledge about underlying psychological and biological mechanisms of decline in body weight. The intention of this project is to investigate whether bariatric surgery is associated with patients' cognitive ability, lifestyle and/or gene expression and metabolomics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 31, 2014
CompletedFirst Posted
Study publicly available on registry
March 12, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMarch 8, 2021
March 1, 2021
9.9 years
January 31, 2014
March 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in gene expression profile (a.o. FTO, BDNF) following a standardized meal (before vs. after surgery)
Gene expression profiling (whole genome analysis, with first interest in FTO and BDNF expression) to assess changes in gene expression before vs. after surgery, and to associate gene expression with weight loss after surgery
1 year
Secondary Outcomes (1)
The effect of bariatric surgery on cognitive functioning (inhibitory control, selective attention)
Measures 1 y, 2 y, and 5 y after surgery.
Eligibility Criteria
Obese patients with bariatric surgery
You may qualify if:
- First bariatric surgery
You may not qualify if:
- More than one surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uppsala Universitylead
- Uppsala University Hospitalcollaborator
Study Sites (1)
Uppsala University Hospital
Uppsala, Sweden
Biospecimen
A fasted blood sample (50 mL) will be taken before and 2h after a standardized meal. Through epigenetic study, we will analyze the changes in DNA methylation after surgery in genes related to metabolism (at the Science for Life Laboratory (SciLifeLab) with 450K Human Meth arrays). In addition, blood samples from these obese patients analyzed (before and after surgery) after ingestion of a predetermined test meal (for example, high protein) to explore changes in metabolites profile. Metabolites in the samples will be quantified by the SciLifeLab.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Magnus Sundbom, MD
Academic Hospital Uppsala
- STUDY DIRECTOR
Helgi Schiöth, Prof
Uppsala University
- STUDY DIRECTOR
Olga Titova, PhD
Uppsala University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2014
First Posted
March 12, 2014
Study Start
January 1, 2014
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
March 8, 2021
Record last verified: 2021-03